Leveraging genetics to treat neurological diseases
Voyager Therapeutics (voyagertherapeutics.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 37th percentile of 12024 Healthcare brands.
Voyager Therapeutics is a biopharmaceutical company focused on developing genetic medicines for severe neurological diseases. It uses proprietary capsid discovery and genetic medicine platforms designed to overcome the blood-brain barrier, enabling targeted delivery of therapeutics. The company works with pharmaceutical partners, researchers, and investors to advance treatments aimed at improving outcomes for patients with complex neurological disorders, including conditions like Alzheimer's disease.
| Brand Name | Voyager Therapeutics |
|---|---|
| Domain | voyagertherapeutics.com |
| Industry | Healthcare |
| Main Competitors | uniQure (81/100), Sarepta Therapeutics (83/100), Regenxbio (74/100), Denali Therapeutics (77/100), 4D Molecular Therapeutics, Passage Bio, Solid Biosciences (77/100), Ionis Pharmaceuticals (79/100) |
Moz Domain Authority 40/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #1,280,608 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To advance transformative genetic medicines that treat and improve the lives of patients with severe neurological diseases." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Instagram, GitHub; no detected presence on X (Twitter), Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Voyager Therapeutics?", Claude could identify the brand as of October 2026. Voyager Therapeutics is a clinical-stage biotechnology company focused on developing gene therapies for severe neurological diseases, using its proprietary TRACER capsid discovery platform to engineer AAV capsids that can cross the blood-brain barrier. Best known for Its TRACER AAV capsid discovery platform used to develop next-generation gene therapy vectors, including partnerships with Novartis and Neurocrine Biosciences f.
When asked "Best brands similar to Voyager Therapeutics?", Claude would recommend Voyager Therapeutics as of October 2026. It's a notable player in the gene therapy and CNS disease space with meaningful pharma partnerships, so it would come up in discussions of biotech companies advancing AAV-based neurological treatments.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Voyager Therapeutics's main competitors in Healthcare: uniQure (81/100), Sarepta Therapeutics (83/100), Regenxbio (74/100), Denali Therapeutics (77/100), Solid Biosciences (77/100).
Sources: Brand Analyzer scan
Voyager Therapeutics has limited AI-search visibility, scoring 39/100 on Brand Analyzer's AI visibility composite (visibility 19, trust 56, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Voyager Therapeutics official site
Voyager Therapeutics scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Voyager Therapeutics official site
Voyager Therapeutics is a biopharmaceutical company that develops genetic medicines intended to treat severe neurological diseases.
Sources: Voyager Therapeutics official site
Voyager Therapeutics develops genetic medicines using proprietary capsid discovery and delivery platforms designed to cross the blood-brain barrier, aiming to treat complex neurological disorders such as Alzheimer's disease.
Sources: Voyager Therapeutics official site
Voyager Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Voyager Therapeutics official site
Voyager Therapeutics offers genetic medicine platforms, including proprietary capsid discovery technology, aimed at developing therapies that can cross the blood-brain barrier to treat severe neurological diseases such as Alzheimer's disease.
Sources: Voyager Therapeutics official site
Voyager Therapeutics is known for its genetic medicine platforms and capsid discovery technology aimed at overcoming the blood-brain barrier to deliver targeted therapies for neurological diseases.
Sources: Voyager Therapeutics official site
Voyager Therapeutics' work is intended for patients with severe neurological diseases, while its platforms and research are engaged with by pharmaceutical partners, researchers, and investors interested in genetic medicine innovation.
Sources: Voyager Therapeutics official site
Voyager Therapeutics scores 39/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Voyager Therapeutics has a weak AI-visibility profile at 39/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (56/100) and its weakest is visibility (19/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,280,608 (Tranco) and a Moz Domain Authority of 40/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data. In a live check, Claude could already identify Voyager Therapeutics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Voyager Therapeutics: Vori Health (74/100), Vivify Health (74/100), Vytal (74/100), Wake Forest University School of Medicine (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.